Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Ehrlich

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
International Journal of Cancer|July 22, 2014
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasisSivan Izraely, Orit Sagi-Assif, Anat Klein, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 28, 2023
The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC ActivationSai Wang, Frederik Link, Mei Han, et al.
International Journal of Cancer|July 12, 2018
The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cellsSivan Izraely, Shlomit Ben-Menachem, Orit Sagi-Assif, et al.
Immunohorizons|April 20, 2022
<i>LY6S,</i> a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral ResistanceMoriya Shmerling, Michael Chalik, Nechama I Smorodinsky, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
International Journal of Cancer|July 22, 2014
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasisSivan Izraely, Orit Sagi-Assif, Anat Klein, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 28, 2023
The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC ActivationSai Wang, Frederik Link, Mei Han, et al.
International Journal of Cancer|July 12, 2018
The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cellsSivan Izraely, Shlomit Ben-Menachem, Orit Sagi-Assif, et al.
Immunohorizons|April 20, 2022
<i>LY6S,</i> a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral ResistanceMoriya Shmerling, Michael Chalik, Nechama I Smorodinsky, et al.
Science Signaling|January 22, 2015
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancerNir Ben-Chetrit, David Chetrit, Roslin Russell, et al.
Pageof 11